Friday, May 8, 2026

North Korea Hails Anti-Japanese Resistance Spirit Ahead of Liberation Day

North Korea emphasizes its commitment to education and national pride while addressing Western shifts on Palestinian recognition.

ADOR Rejects Min Hee Jin’s CEO Return Amid NewJeans Turmoil

ADOR, the label under HYBE that houses NewJeans, has stated that it cannot accept Min Hee Jin's demand to return to her role as CEO.

Will North Korea Inform its Citizens About South Korea-Cuba Diplomatic Relations?

There is speculation that North Korea will not inform its citizens regarding the diplomatic relationship establishment between South Korea and Cuba...

Tag: GC Biopharma

GC Biopharma Presents Aggregation Study of Alyglo IVIG… A New Benchmark for Safe Immunotherapy

GC Biopharma USA will present findings on IVIG formulations, highlighting Alyglo's lower protein aggregation and improved stability at NHIA 2026.

GC Biopharma Targets Full Utilization of Plasma Centers with FDA Approval of ABO Plasma

GC Biopharma's ABO Plasma gains FDA approval for its Laredo center, enhancing plasma sourcing and operational efficiency ahead of schedule.

GC Biopharma’s Varicella Vaccine “VARICELLAJU” Wins Approval in Guatemala

GC Biopharma's varicella vaccine VARICELLAJU gains marketing approval in Guatemala, marking its Latin American debut and ensuring safety.

GC Biopharma Corp Soars After Eight Years on the Back of Immunodeficiency Drug Alyglo, Posting Results in U.S. Market Push

GC Biopharma Corp breaks its fourth-quarter deficit with ALYGLO's success, achieving $106M in annual revenue and plans for future growth.

Top News

- Our Sponsors Ad -

Follow us